Inhibitors of Rho kinase (ROCK) signaling revert the malignant phenotype of breast cancer cells in 3D context

Masahiro Matsubara(Lawrence Berkeley National Laboratory), Mina J. Bissell(Lawrence Berkeley National Laboratory)
Oncotarget
May 17, 2016
Cited by 61


Related Papers